Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted
Thesis Summary

Nebius has reached a major operating inflection: second-quarter 2026 revenue was USD 582.3 million, up 454% year over year, while adjusted EBITDA improved to USD 236.2 million from a USD 21.0 million loss. The opportunity remains unusually capital intensive, however, with FY2026 capital-expenditure guidance of USD 20-25 billion and a USD 5.75 billion convertible-note financing completed after quarter-end. The balance between exceptional growth and material execution, leverage and dilution exposure supports a Hold rather than a more aggressive recommendation.

Sign in / Sign up to read more
This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.
Street view · analyst 12-month targets13 analysts · as of 18 Aug 2026
Low · most bearish analyst$144.00
Mean target$276.46
High · most bullish analyst$410.00
Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.
Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026
Scenarios · 12-month scenario targetsAnchored at research date
Bear CaseDownside scenario
$144.0027%

Revenue falls below the USD 3.0 billion guidance floor, adjusted EBITDA margin undershoots approximately 40%, or capital expenditures exceed USD 25 billion. Under that outcome, capacity deployment would consume more capital than expected while the enlarged convertible-note stack and associated share issuance amplify financing and dilution pressure.

Base CaseCentral scenario
$276.4656%
Matches the consensus mean

Nebius delivers within its FY2026 revenue and adjusted EBITDA guidance while executing the planned capacity build, but the scale of capital expenditures and convertible financing keeps dilution and execution risk elevated.

Bull CaseUpside scenario
$410.0017%

Nebius delivers near the upper end of its USD 3.0-3.4 billion FY2026 revenue guidance, sustains approximately 40% adjusted EBITDA margins and keeps capital expenditures within the USD 20-25 billion range. The August convertible financing funds timely data-center and GPU deployment, allowing strong demand to translate into durable operating leverage.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits
  • Second-quarter 2026 revenue increased 454% year over year to USD 582.3 million.
  • Adjusted EBITDA improved to USD 236.2 million in Q2 2026 from a USD 21.0 million loss in Q2 2025.
  • The USD 5.75 billion convertible-note offering provides substantial additional funding for data centers, GPUs and the full-stack AI cloud.
Sign in / Sign up to read more
Key Investment Risks
  • The expansion plan is highly capital intensive: purchases of property, equipment and intangible assets totaled USD 8.1303 billion in the first half of 2026, while FY2026 capital-expenditure guidance is USD 20-25 billion.
  • GAAP profitability still trails adjusted performance: Q2 2026 produced a USD 175.9 million operating loss and a USD 190.4 million net loss from continuing operations.
  • The August 2026 exchange of USD 800 million of existing convertible notes resulted in approximately 15.8 million Class A shares being issued, creating immediate dilution and potential market selling pressure.
  • The new USD 5.75 billion convertible-note financing increases fixed claims and potential future dilution even though it funds the capacity expansion.
Sign in / Sign up to read more

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Explore this dossier

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.